Myriad Genetics
MYGN
#7403
Rank
โ‚ฌ0.38 B
Marketcap
4,07ย โ‚ฌ
Share price
-1.16%
Change (1 day)
-44.64%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -โ‚ฌ0.37 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are โ‚ฌ0.82 Billion. In 2024 the company made an earning of -โ‚ฌ0.11 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.37 Billion246.13%
2024 -โ‚ฌ0.11 Billion-53.49%
2023 -โ‚ฌ0.23 Billion88.72%
2022 -โ‚ฌ0.12 Billion172.08%
2021 -โ‚ฌ43.75 Million
2019 -โ‚ฌ22.79 Million-175.14%
2018 โ‚ฌ30.32 M-70.81%
2017 โ‚ฌ0.10 B22.22%
2016 โ‚ฌ84.98 M-38.8%
2015 โ‚ฌ0.13 B-6.12%
2014 โ‚ฌ0.14 B-41.07%
2013 โ‚ฌ0.25 B46.67%
2012 โ‚ฌ0.17 B15.84%
2011 โ‚ฌ0.14 B17.6%
2010 โ‚ฌ0.12 B-15.96%
2009 โ‚ฌ0.14 B
2007 -โ‚ฌ36.11 Million40.96%
2006 -โ‚ฌ25.62 Million
2003 -โ‚ฌ29.75 Million34.8%
2002 -โ‚ฌ22.07 Million89.21%
2001 -โ‚ฌ11.67 Million3.93%
2000 -โ‚ฌ11.23 Million21.76%
1999 -โ‚ฌ9.22 Million-25.61%
1998 -โ‚ฌ12.39 Million38.83%
1997 -โ‚ฌ8.93 Million-24.26%
1996 -โ‚ฌ11.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
โ‚ฌ7.33 B-2,122.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-โ‚ฌ0.16 Billion-56.46%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.41 B-215.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-โ‚ฌ30.3 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚ฌ0.86 B-337.87%๐Ÿ‡บ๐Ÿ‡ธ USA